![]() |
市場調查報告書
商品編碼
1861118
全球經腸營養設備市場:市場規模、佔有率和趨勢分析(2026-2032 年)Enteral Feeding Device Market Size, Share, and Trends Analysis | Global | 2026-2032 | Includes: Feeding Pumps, Enteral Feeding sets, and Enteral Feeding Tubes |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球經腸營養設備市場預計到2025年將超過34億美元。預計該市場將以3.2%的複合年成長率成長,到2032年達到約43億美元。
本報告涵蓋腸道餵食幫浦、經腸營養裝置和經腸營養管,這些產品共同構成了全球完整的經腸營養設備市場。報告量化了銷售、平均售價、市場價值、成長率和企業市場占有率,並分析了市場趨勢和促進因素、近期併購活動以及技術發展。報告提供截至2022年的歷史數據,並預測至2032年。
它反映了世界各地的醫療機構如何評估醫院、療養院和居家照護環境中的經腸營養技術,重點關注患者的舒適度、成本效益和程序安全性。
市場概覽
經腸營養裝置對於無法透過口服攝取滿足營養需求的患者至關重要。這些裝置包括幫浦、餵食管和輸液器,它們以可控的方式將液態營養物質直接輸送到消化道。
過去十年,經腸營養已成為長期患者照護的重要組成部分,尤其是在慢性病、神經系統疾病、癌症和老齡化相關疾病患者群體中。營養不良和胃腸道疾病盛行率的不斷上升,以及醫療保健服務可近性和報銷政策的改善,持續推動市場成長。
兒童經腸營養是推動整體市場擴張的重要因素。兒童病例的報銷率約為成人的三倍,這鼓勵醫生更頻繁地進行此類手術。家長意識的提高以及與經腸營養相關的社會偏見的減少,使得家長更容易接受這種治療方法。因此,兒童病例正成為製造商實現成長和差異化的關鍵領域。
此外,對替換裝置(尤其是低輪廓球囊和非球囊導管)的需求持續推動市場成長。這些替換手術通常可以在家中或護理機構進行,而無需住院,這既方便了患者,也為醫療機構節省了成本。
儘管價格仍面臨壓力,技術創新也在放緩,但整體手術量和患者接受率都在增加,這些趨勢支撐著已開發和新興醫療保健市場在全球範圍內的穩定收入成長。
市場促進因素
兒科經腸營養程序
兒童經腸營養的興起是推動市場發展最重要的因素之一。更高的報銷率和更佳的設備安全性促使醫生向兒童推薦經腸營養。家長也越來越意識到早期營養介入的益處,並且比以往更容易接受管飼。
社會偏見的減少以及經腸營養療效的普及,促使人們能夠對嬰幼兒進行早期療育,以對抗飲食障礙。預計這些趨勢將在預測期內持續,為兒科營養生產商帶來巨大的長期成長機會。
替換裝置
在全球市場,替換式餵食管正推動持續的收入成長。雖然初次置入通常需要在醫療機構進行,但更換過程通常可以在門診病人或居家照護環境中完成。
這種便利性降低了操作難度,使患者能夠更長時間地使用經腸營養系統。由於維護更簡單、舒適度更高,帶氣囊和不帶氣囊的低位腸內營養管都越來越受歡迎。因此,替換產品對銷售量和整體市場穩定性做出了顯著貢獻。
細管
低位腸內營養管的隱藏設計和較高的患者舒適度提高了經腸營養的接受度。這些導管較不易被察覺,並提供更大的活動自由度,進而改善病患的生活品質。
特別是低位氣球管,正日益取代標準的經皮視鏡胃造瘻術(PEG)管。重要的是,球囊管的日益普及不僅取代了現有產品的銷量,而且還透過吸引以前拒絕長期營養干預的新患者,擴大了整體市場。
家庭護理和替代護理的成長
向家庭經腸營養的轉變是另一個主要的市場促進因素。隨著醫療系統尋求降低住院成本,越來越多的患者出院時都配備了經腸營養系統。這些設備操作簡單、便攜且安全,使得看護者和患者能夠在極少監督的情況下在家中管理營養。
這種轉變也使製造商受益,因為定期購買餵食器和替換管材可以帶來持續的收入。小型電池驅動腸內營養泵的持續發展進一步推動了居家照護領域的擴張。
市場限制
缺乏新技術
近年來,經腸營養設備市場技術進步有限。核心產品設計基本上保持不變,導致平均售價持平甚至下降。儘管在易用性和材料設計方面有所改進,但鮮有重大突破足以支撐其高價。
此外,更換手術過程令人不適,降低了患者接受新型號產品的意願。缺乏引人注目的技術創新,加上持續的價格壓力,預計將在2032年之前抑制價格成長。
併發症風險
儘管經腸營養是一種成熟的治療方法,但與導管相關的併發症仍然是臨床上關注的問題。常見問題包括導管移位、滲漏、感染和代謝失衡。這些風險使得醫生和患者在考慮長期經腸營養都猶豫不決。
持續優先考慮安全性而非療效的做法可能會減緩新產品或先進產品的推廣應用。如果出現療效相當但併發症風險較低的替代營養輸送技術,經腸營養市場在某些臨床領域可能會面臨競爭壓力。
兌換限制
雖然兒科醫療的報銷率較為優惠,但成人醫療的報銷政策因市場而異。在保險覆蓋範圍限制嚴格的地區,醫院可能不願意投資昂貴的輸液幫浦及其配件。這些限制,加上開發中國家缺乏統一的報銷框架,限制了平均售價的成長,並延緩了設備的更新換代週期。
目標市場和數據範圍
定量範圍
市場規模、市佔率、市場預測、成長率、銷售量、平均售價
定性範圍
成長趨勢、限制因素、競爭分析、競爭對手SWOT分析、併購、公司概況和產品系列、FDA召回事件、顛覆性技術、疾病概述,這些因素共同影響經腸營養設備的需求。
時期
基準年為2025年,預測期間為2026-2032年,歷史資料為2022-2024年。
數據來源
主要研究內容包括:對行業高管、臨床醫生和採購專業人員的訪談、政府資料庫、進出口記錄以及iData Research的內部資料儲存庫。
方法注記
銷售模型是透過將單位數量乘以平均售價 (ASP) 來建立的,並根據假設的護理機構利用率和更換率檢驗。
目標市場及區隔
腸道餵食幫浦
經腸營養套裝
經腸營養管
競爭分析
Avanos Medical在2025年引領了全球經腸營養管市場。該公司前身為Halyard Health,在2018年將其外科和感染預防業務出售給Owens & Minor後更名為Avanos Medical。 2016年收購CORPAK MedSystems進一步鞏固了其在經腸營養領域的地位。 Avanos的產品線以其可靠性、安全性和符合ENFit®連接器標準而廣受認可,確保了其在醫院和家庭護理機構之間的兼容性。
費森尤斯卡比是全球經腸營養設備市場第二大競爭者。憑藉其德國血統和在當地享有的產品品質聲譽,該公司在德國、奧地利和瑞士市場擁有尤為強大的領先地位。費森尤斯卡比銷售的Amika®腸道餵食幫浦和符合ENFit®標準的Freka®營養管廣泛應用於醫院和養老院。
2025年,康德樂在全球市場排名第三。該公司的優勢在於其全面的Kangaroo™產品線,包括輸液幫浦、輸液管和輸液器套裝。 Kangaroo™系統廣泛應用於醫院、居家醫療和長期照護機構,以其簡單性、安全性和與ENFit®相容的設計而聞名。憑藉其廣泛的分銷網路和對產品可靠性的重視,康德樂在多個地區保持主導地位。
整體而言,競爭格局持續溫和整合,這三家公司總合佔了相當大的市場佔有率。亞太和拉丁美洲的區域製造商主要在價格上競爭,提供具成本效益的產品以滿足新興市場日益成長的需求。
科技與臨床趨勢
ENFit® 標準化持續推動全球應用,提高病患安全並降低誤連接的風險。
可攜式和電池驅動的幫浦在家庭和門診使用中越來越受歡迎,提高了患者的活動能力。
由於提高了患者的舒適度和美觀性,低輪廓餵食管仍然是成長最快的產品區隔市場。
引入增強材料和防堵塞塗層,以提高管道壽命並減少維護。
追蹤餵食參數和設備性能的數位監控系統正在逐漸出現,主要出現在先進的醫療保健市場。
與居家醫療的融合不斷擴大,簡化的營養包被引入醫院外,供看護者使用。
地區
本期內容涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
調查方法附錄與簡稱
圖表清單
圖表列表
調查方法
全球關稅的影響
經腸營養設備市場
The global enteral feeding device market was valued at over $3.4 billion in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.2 percent to reach nearly $4.3 billion by 2032.
This report covers enteral feeding pumps, enteral feeding sets, and enteral feeding tubes, which together make up the complete global market for enteral feeding devices. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and it analyzes market drivers and limiters, recent mergers and acquisitions, and technology trends. The report provides historical data to 2022 and forecasts through 2032.
The scope reflects how healthcare systems worldwide evaluate enteral feeding technologies across hospitals, nursing homes, and home care environments, focusing on patient comfort, cost efficiency, and procedural safety.
Market Overview
Enteral feeding devices are essential for providing nutritional support to patients who are unable to meet their dietary needs through oral intake. These devices include pumps, feeding tubes, and sets used for the controlled delivery of liquid nutrition directly into the gastrointestinal tract.
Over the last decade, enteral feeding has become a critical component of long-term patient care, particularly among populations affected by chronic illnesses, neurological disorders, cancer, and age-related conditions. Market growth continues to be supported by the expanding prevalence of malnutrition and gastrointestinal disease, coupled with improvements in healthcare access and reimbursement policies.
Pediatric enteral feeding procedures are a notable contributor to overall market expansion. Reimbursement rates for pediatric cases are approximately three times higher than for adults, encouraging physicians to perform these procedures more frequently. Greater parental awareness and the reduction of social stigma associated with enteral feeding have made parents more open to this therapy for children. As a result, pediatric cases are becoming a key area of growth and differentiation for manufacturers.
Additionally, replacement device demand-particularly for low-profile balloon and non-balloon tubes-continues to strengthen market performance. These replacement procedures can often be carried out in home or nursing care settings rather than hospitals, providing convenience for patients and reducing costs for providers.
Although pricing remains under pressure and technological innovation has slowed, overall procedure volumes and patient adoption are rising. This trend supports steady global revenue growth across both developed and emerging healthcare markets.
Market Drivers
Pediatric Enteral Feeding Procedures
The rise in pediatric enteral feeding procedures is one of the most significant market drivers. Physicians are more likely to recommend enteral feeding for children given the higher reimbursement rates and improved device safety. Parents are increasingly aware of the benefits of early nutritional intervention and are more accepting of feeding tubes than in the past.
The reduction in social stigma, combined with widespread education on the effectiveness of enteral feeding, has led to earlier intervention for infants and young children who struggle with feeding disorders. These trends are expected to continue over the forecast period, representing a major long-term growth opportunity for manufacturers targeting pediatric applications.
Replacement Devices
Replacement feeding tubes are driving recurring revenue streams across the global market. While initial placements typically require a clinical setting, replacements can often be managed in outpatient or home care environments.
This convenience reduces procedural barriers and encourages patients to continue using enteral feeding systems for extended periods. Both balloon and non-balloon low-profile tubes are gaining adoption due to their ease of maintenance and improved comfort. As a result, replacement products are contributing significantly to unit sales and overall market stability.
Low-Profile Tubes
The discreet design and greater patient comfort offered by low-profile enteral tubes have increased acceptance of enteral feeding. These tubes are less visible and allow greater freedom of movement, improving patient quality of life.
Low-profile balloon tubes, in particular, are increasingly replacing standard percutaneous endoscopic gastrostomy (PEG) tubes. Importantly, their growing popularity is not merely substituting existing sales but expanding the total market by attracting new patients who previously declined long-term feeding interventions.
Home and Alternate Care Growth
The shift toward home-based enteral nutrition is another key market driver. As healthcare systems aim to reduce inpatient costs, more patients are being discharged with enteral feeding systems. Improved device usability, portability, and safety features enable caregivers and patients to manage feeding at home with minimal supervision.
This transition also benefits manufacturers, as recurring purchases of feeding sets and replacement tubes generate ongoing revenue. Continued development of compact, battery-operated enteral pumps further supports the expansion of the home care segment.
Market Limiters
Lack of New Technology
The enteral feeding device market has seen limited technological advancement in recent years. Core product designs have remained largely unchanged, contributing to flat or declining ASPs. While incremental improvements in usability and material design exist, there have been few major breakthroughs that would justify premium pricing.
Patients also demonstrate limited interest in adopting new models since replacement procedures can be uncomfortable. The lack of compelling innovation, combined with ongoing pricing pressure, is expected to maintain subdued price growth through 2032.
Risk of Complications
Although enteral feeding is a well-established therapy, device-related complications remain a clinical concern. Common issues include tube dislodgment, leakage, infection, and metabolic imbalances. These risks can deter both physicians and patients from prolonged enteral feeding.
As safety continues to be prioritized over efficiency, the adoption of new or advanced products can slow. If alternative nutritional delivery technologies emerge that offer equal efficacy with lower complication risk, the enteral feeding market could face competitive pressure in certain clinical segments.
Reimbursement Constraints
While reimbursement rates for pediatric procedures are favorable, adult reimbursement policies remain uneven across markets. In regions with strict coverage limits, hospitals may be reluctant to invest in premium pumps or accessories. These constraints, combined with the absence of uniform reimbursement frameworks in developing economies, limit ASP growth and delay device replacement cycles.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative Coverage
Growth trends, limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls, disruptive technologies, and disease overviews that shape demand for enteral feeding devices.
Time Frame
Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
Data Sources
Primary interviews with industry executives, clinicians, and procurement specialists; government databases; import and export records; and the iData Research internal data repository.
Method Note
Revenue is modeled from units multiplied by ASP, validated with utilization rates and replacement assumptions across care settings.
Markets Covered and Segmentation
Enteral Feeding Pump
Enteral Feeding Set
Enteral Feeding Tube
Competitive Analysis
Avanos Medical led the global enteral feeding tube market in 2025. Formerly known as Halyard Health, the company rebranded as Avanos Medical in 2018 following the divestment of its surgical and infection prevention business to Owens & Minor. Its acquisition of CORPAK MedSystems in 2016 strengthened its position in the enteral feeding segment. Avanos' product lines are widely recognized for their reliability, safety, and compliance with ENFit(R) connector standards, ensuring compatibility across hospitals and home care providers.
Fresenius Kabi ranked as the second-largest competitor in the global market for enteral feeding devices. The company's leadership is particularly strong in Germany, Austria, and Switzerland, supported by its German origins and regional reputation for product quality. Fresenius Kabi markets the Amika(R) enteral feeding pump and ENFit(R)-compliant Freka(R) feeding tubes, which are used extensively in both hospital and long-term care environments.
Cardinal Health ranked third in the global market in 2025. The company's strength lies in its comprehensive Kangaroo(TM) product line, which includes feeding pumps, tubes, and sets. The Kangaroo(TM) systems are widely used across hospitals, home healthcare, and long-term care facilities, valued for their simplicity, safety, and ENFit(R)-compatible design. Cardinal Health's broad distribution networks and focus on reliability have enabled it to maintain a leading position in multiple regions.
Overall, the competitive landscape remains moderately consolidated, with these three companies collectively accounting for a substantial share of total market revenues. Regional manufacturers in Asia-Pacific and Latin America compete primarily on price, offering cost-effective products to meet growing demand in emerging markets.
Technology and Practice Trends
ENFit(R) standardization continues to drive global adoption, improving patient safety and reducing the risk of misconnections.
Portable and battery-powered pumps are gaining popularity for home and ambulatory use, enhancing patient mobility.
Low-profile feeding tubes remain the fastest-growing product subsegment due to improved patient comfort and aesthetic appeal.
Reinforced materials and anti-clog coatings are being introduced to improve tube longevity and reduce maintenance frequency.
Digital monitoring systems that track feeding parameters and device performance are emerging gradually, primarily in advanced healthcare markets.
Home healthcare integration continues to expand, with simplified feeding sets designed for caregiver use outside hospital settings.
Geography
This edition covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Methodology Appendix and Acronym Glossary
Where are the largest and fastest-growing opportunities within the global enteral feeding device market
How are pediatric procedures and replacement trends driving sustained unit growth
What are the key limitations to ASP expansion, and how do manufacturers manage pricing pressure
Which product innovations, such as low-profile tubes and portable pumps, are shaping the market outlook
How are leading companies-Avanos Medical, Fresenius Kabi, and Cardinal Health-differentiating their portfolios and maintaining share
What procedural and reimbursement factors will shape growth through 2032
The Global Enteral Feeding Device Market Report from iData Research answers these questions with detailed procedure-based models, company share data, and price trend analysis. Use it to evaluate market potential, plan commercial strategy, and align R&D initiatives with emerging clinical needs.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Enteral Feeding Device Market